Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man

@article{Hinz2008AcetaminophenI,
  title={Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man},
  author={Burkhard Hinz and Olga Cheremina and Kay Brune},
  journal={The FASEB Journal},
  year={2008},
  volume={22},
  pages={383 - 390}
}
For more than three decades, acetaminophen (INN, paracetamol) has been claimed to be devoid of significant inhibition of peripheral prostanoids. Meanwhile, attempts to explain its action by inhibition of a central cyclooxygenase (COX)‐3 have been rejected. The fact that acetaminophen acts functionally as a selective COX‐2 inhibitor led us to investigate the hypothesis of whether it works via preferential COX‐2 blockade. Ex vivo COX inhibition and pharma‐cokinetics of acetaminophen were assessed… Expand
Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
TLDR
It is suggested with specificity to human in vivo physiology that ACT is an effective antipyretic (COX2 preference for PG synthesis) and can reduce afebrile core temperature and inhibition of COX isoforms are determined by subtle and nuanced physiological variations. Expand
Inhibition of lipolysis: a novel explanation for the hypothermic actions of Acetaminophen in Non-Febrile Rodents.
TLDR
Both the antipyretic and hypothermia induced by acetaminophen and related compounds could be attributed to the direct inhibition of lipolysis and mitochondrial function, rather than cyclooxygenase inhibition centrally. Expand
Paracetamol and cyclooxygenase inhibition: is there a cause for concern?
TLDR
Paracetamol's fast elimination and consequently short-lived COX-2 inhibition, which requires repetitive dosing, should be definitely considered to avoid overdosage leading to hepatotoxicity. Expand
Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin
TLDR
Urinary excretion of prostacyclin metabolite, PGI‐M; COX‐2 inhibition and 11‐dehydro thromboxane B2 and Tx‐M excretion were measured after 1 dose and 5 days of dosing to assess the effect of acetaminophen versus indomethacin versus placebo on cyclooxygenase enzymes. Expand
Drug Insight: cyclo-oxygenase-2 inhibitors—a critical appraisal
TLDR
Off-label long-term use of COX2 inhibitors in patients with a history of colorectal adenomas in well-designed, placebo-controlled trials showed that treatment with these agents is associated with an increased rate of cardiovascular adverse effects. Expand
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings
TLDR
The result is that paracetamol does not suppress the severe inflammation of rheumatoid arthritis and acute gout but does inhibit the lesser inflammation resulting from extraction of teeth and is also active in a variety of inflammatory tests in experimental animals. Expand
Acetaminophen reduces lipopolysaccharide-induced fever by inhibiting cyclooxygenase-2
TLDR
Findings reveal that acetaminophen, similar to aspirin and other non-steroidal anti-inflammatory drugs, is antipyretic by inhibiting cyclooxygenase-2, and not by inhibited mPGES-1 or signaling cascades downstream of prostaglandin E₂. Expand
New insights into the use of currently available non-steroidal anti-inflammatory drugs
TLDR
A better understanding of the inhibitory activity and COX-1/COX-2 selectivity of an NSAID at therapeutic doses, based on pharmacokinetic and pharmacodynamic properties can guide the selection of appropriate NSAIDs for pain management. Expand
Loss of hypothermic and anti-pyretic action of paracetamol in cyclooxygenase-1 knockout mice is indicative of inhibition of cyclooxygenase-1 variant enzymes.
TLDR
Evidence is provided which suggests that the hypothermic and now anti-pyretic actions of paracetamol are mediated through inhibition of a COX-1 variant enzyme. Expand
Current etiological comprehension and therapeutic targets of acetaminophen-induced hepatotoxicity.
TLDR
The most current advances to elucidate the etiological factors and therapeutic targets that could provide better strategies for the management of APAP-induced hepatotoxicity are reviewed. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 57 REFERENCES
Mechanism of action of acetaminophen: is there a cyclooxygenase 3?
  • R. Botting
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2000
TLDR
COX-3 may be a product of the same gene that encodes COX-2, but have different molecular characteristics, because acetaminophen is a weak inhibitor in vitro of both cyclooxygenase (COX)-1 and COx-2. Expand
Mechanism of acetaminophen inhibition of cyclooxygenase isoforms.
TLDR
Results are consistent with a mechanism of inhibition of acetaminophen in which it acts to reduce the active oxidized form of COX to the resting form, consistent with the known tissue selectivity of acetamine. Expand
Mechanism of Action of Paracetamol
TLDR
There is considerable evidence that the analgesic effect of paracetamol is central and is due to activation of descending serotonergic pathways, but its primary site of action may still be inhibition of PG synthesis. Expand
Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases
TLDR
The hypothesis that the clinical action of acetaminophen is mediated by inhibition of PGHS activity, and that hydroperoxide concentration contributes to its cellular selectivity, is supported. Expand
Actions of paracetamol on cyclooxygenases in tissue and cell homogenates of mouse and rabbit.
TLDR
The hypothesis that paracetamol selectively inhibits a COX enzyme which is different from COX1 or COX-2 and may be a variant ofCOX-1 is supported. Expand
Pharmacological analysis of cyclooxygenase-1 in inflammation.
  • C. Smith, Y. Zhang, +7 authors P. Isakson
  • Chemistry, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1998
TLDR
The results suggest that, in addition to the role of peripherally produced PGs, there is a critical, centrally mediated neurological component to inflammatory pain that is mediated at least in part by COX-2. Expand
Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties
TLDR
The aim of this review is to evaluate the literature that seeks to point out critical theoretical and methodological limitations of the COX-3 studies that led several investigators to scientifically questionable conclusions. Expand
COX‐3—a virtual pain target in humans?
  • J. Schwab, T. Beiter, +4 authors H. Schluesener
  • Biology, Medicine
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2003
A long-sought molecule (1) was recently identified as acting independent of COX-1/-2 (2). The potent analgesic and anti-pyretic actions of acetaminophen lacking anti-inflammatory potency suggestedExpand
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression
TLDR
Comparison of canineCOX-3 activity with murine COX-1 and -2 demonstrates that this enzyme is selectively inhibited by analgesic/antipyretic drugs such as acetaminophen, phenacetin, antipyrine, and dipyrone, and is potently inhibited by some nonsteroidal antiinflammatory drugs. Expand
Dose-dependent Inhibition of Platelet Function by Acetaminophen in Healthy Volunteers
TLDR
Acetaminophen, which is a weak inhibitor of platelet cyclooxygenase 1, has a dose-dependent antiaggregatory effect that may become clinically significant in patients with intrinsic or drug-induced impairment of hemostasis. Expand
...
1
2
3
4
5
...